IRMD Iradimed PE ratio, current and historical analysis
The current PE ratio for Iradimed stock as of Feb 25, 2025 is 36.9. This is calculated based on the TTM EPS of $1.48 and the stock price of $54.61 per share. The PE ratio marks an increase of 14% from its last 4 quarters average of 32.4.
IRMD PE ratio history
The average historical PE ratio of Iradimed for the last ten years is 61.32. The current P/E ratio of 36.9 is 40% lower than the historical average. Looking back at the last ten years, IRMD's PE ratio peaked in the Mar 2021 quarter at 322.13, when the price was $25.77 and the EPS was $0.08. The lowest point was in the Dec 2016 quarter, when it reached 16.32 with a price of $11.1 and an EPS of $0.68.
Iradimed PE ratio by year
Maximum annual increase: 1,756.62% in 2017
Maximum annual decrease: -86.32% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 34.9 | 25.81% | $47.47 | $1.36 |
| 2022 | 27.74 | -54.38% | $28.29 | $1.02 |
| 2021 | 60.8 | -68% | $46.21 | $0.76 |
| 2020 | 190 | 590.66% | $22.8 | $0.12 |
| 2019 | 27.51 | -33.65% | $23.38 | $0.85 |
| 2018 | 41.46 | -86.32% | $24.46 | $0.59 |
| 2017 | 303 | 1,756.62% | $15.15 | $0.05 |
| 2016 | 16.32 | -60.41% | $11.1 | $0.68 |
| 2015 | 41.22 | -26.51% | $28.03 | $0.68 |
| 2014 | 56.09 | N/A | $12.9 | $0.23 |
| 2013 | N/A | N/A | N/A | $0.28 |
| 2012 | N/A | N/A | N/A | $0.14 |
Iradimed PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 33.98 | 14.45% | $50.29 | $1.48 |
| Jun 2024 | 29.69 | -4.16% | $43.94 | $1.48 |
| Mar 2024 | 30.98 | -11.23% | $43.99 | $1.42 |
| Dec 2023 | 34.9 | 1.45% | $47.47 | $1.36 |
| Sep 2023 | 34.4 | -16.42% | $44.37 | $1.29 |
| Jun 2023 | 41.16 | 14.02% | $47.74 | $1.16 |
| Mar 2023 | 36.1 | 30.14% | $39.35 | $1.09 |
| Dec 2022 | 27.74 | -3.11% | $28.29 | $1.02 |
| Sep 2022 | 28.63 | -16.48% | $30.06 | $1.05 |
| Jun 2022 | 34.28 | -35.01% | $33.94 | $0.99 |
| Mar 2022 | 52.75 | -13.24% | $44.84 | $0.85 |
| Dec 2021 | 60.8 | -11.31% | $46.21 | $0.76 |
| Sep 2021 | 68.55 | -13.76% | $33.59 | $0.49 |
| Jun 2021 | 79.49 | -75.32% | $29.41 | $0.37 |
| Mar 2021 | 322.13 | 69.54% | $25.77 | $0.08 |
IRMD average PE ratio chart
Currently, IRMD's PE ratio is higher than the 3-year average, but it is lower than its 5 and 10-year averages.
IRMD PE vs peers
IRMD's PE ratio stands lower than its peer stocks DXCM and COO, but it is higher than EW's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| EW Edwards Lifesciences Corp | 10.4 | $42.56B |
| IRMD Iradimed Corp | 37.33 | $700.14M |
| COO Cooper Companies Inc | 46.83 | $18.41B |
| DXCM Dexcom Inc | 61.89 | $35.31B |
Frequently asked questions
What is Iradimed's PE ratio?
IRMD stock has a price to earnings ratio of 36.9 as of Feb 25, 2025.
What is the 3-year average PE ratio for Iradimed (IRMD)?
The 3-year average price to earnings ratio for IRMD stock is 34.96.
What is the 5-year average PE ratio for Iradimed (IRMD)?
The 5-year average price to earnings ratio for IRMD stock is 65.29.
What is the highest PE ratio for IRMD?
Over the last ten years, the Mar 2021 quarter recorded the highest quarterly PE ratio at 322.13.
How does the current PE ratio for IRMD compare to its historical average?
The current PE ratio of IRMD is 40% lower than the 10-year historical average.
How is IRMD's PE ratio calculated (Iradimed PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Feb 25, 2025), Iradimed's share price is $54.61. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.48. Therefore, Iradimed's PE ratio for today is 36.9. PE RATIO(36.9) = STOCK PRICE($54.61) / TTM EPS($1.48)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.